BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22083596)

  • 1. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.
    Kisiel JB; Yab TC; Taylor WR; Chari ST; Petersen GM; Mahoney DW; Ahlquist DA
    Cancer; 2012 May; 118(10):2623-31. PubMed ID: 22083596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
    Kisiel JB; Yab TC; Nazer Hussain FT; Taylor WR; Garrity-Park MM; Sandborn WJ; Loftus EV; Wolff BG; Smyrk TC; Itzkowitz SH; Rubin DT; Zou H; Mahoney DW; Ahlquist DA
    Aliment Pharmacol Ther; 2013 Mar; 37(5):546-54. PubMed ID: 23347191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance.
    Kisiel JB; Yab TC; Taylor WR; Mahoney DW; Ahlquist DA
    Dig Dis Sci; 2014 Aug; 59(8):1764-7. PubMed ID: 24993691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Johnson DH; Taylor WR; Aboelsoud MM; Foote PH; Yab TC; Cao X; Smyrk TC; Loftus EV; Mahoney DW; Ahlquist DA; Kisiel JB
    Inflamm Bowel Dis; 2016 Jul; 22(7):1559-67. PubMed ID: 27104828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is methylation analysis of
    Park SK; Baek HL; Yu J; Kim JY; Yang HJ; Jung YS; Choi KY; Kim H; Kim HO; Jeong KU; Chun HK; Kim K; Park DI
    Intest Res; 2017 Oct; 15(4):495-501. PubMed ID: 29142517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
    Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
    Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.
    Ahlquist DA; Zou H; Domanico M; Mahoney DW; Yab TC; Taylor WR; Butz ML; Thibodeau SN; Rabeneck L; Paszat LF; Kinzler KW; Vogelstein B; Bjerregaard NC; Laurberg S; Sørensen HT; Berger BM; Lidgard GP
    Gastroenterology; 2012 Feb; 142(2):248-56; quiz e25-6. PubMed ID: 22062357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
    Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
    Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of methylated markers with a multiplex methylation-specific technology.
    Zou H; Allawi H; Cao X; Domanico M; Harrington J; Taylor WR; Yab T; Ahlquist DA; Lidgard G
    Clin Chem; 2012 Feb; 58(2):375-83. PubMed ID: 22194633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
    Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
    Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
    Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
    Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
    Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
    Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.